Navigation Links
Pharmatech Oncology Receives Phase 2 SBIR Funding for Just-In-Time Enrollment Model
Date:8/9/2012

DENVER, Aug. 9, 2012 /PRNewswire/ -- Pharmatech Oncology announces the award of its phase 2 Small Business Innovative Research (SBIR) project, entitled A Patient Centered Approach to Enrolling Rare Cancer Patients in Clinical Trials, to be funded through the National Cancer Institute (NCI).

Pharmatech Oncology has developed an innovative enrollment methodology called Just-In-Time (JIT) to improve enrollment rates into cancer clinical trials, which often see significant delays due to slow patient enrollment.  The major challenge in developing more effective anti-cancer drugs is the time it takes to complete clinical trials demonstrating the safety and efficacy of investigational new drugs. With only an estimated 3 to 5 percent of adult cancer patients participating in clinical trials, and potentially even fewer being offered the opportunity, JIT provides patients with on-demand access to cancer clinical trials and investigational treatments.

In Phase 1 of the SBIR project, Pharmatech Oncology demonstrated that cancer trial enrollment rates can be increased by making specific clinical trials available to a network of research ready centers (Click this link to see the abstract: http://intl-dij.sagepub.com/content/46/4/472.abstract). The JIT enrollment model puts patients first in the research process, prioritizing selection of the most appropriate therapy, and utilizing highly efficient workflow to enroll individual cancer patients into a trial in 10 days or less.

The Phase 2 project addresses the scalability of the JIT enrollment methodology as an industry-wide solution, but even more exciting is its focus on aligning patient genetic and molecular characteristics with personalized therapy. The principal investigator of the project, Dr. Matthew Wiener, believes, "The JIT enrollment methodology is ideally positioned to support the development of targeted cancer m
'/>"/>

SOURCE Pharmatech Oncology, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. WuXi PharmaTech Announces First-Quarter 2012 Results
2. Industry Leading Pharmaceutical News Website in-Pharmatechnologist.com Refocused and Relaunched
3. WuXi PharmaTech Files 2011 Annual Report on Form 20-F
4. Champions Oncology Reports Resignation Of Director
5. Center for Medicare & Medicaid Innovation Awards $19 Million Grant to Develop Oncology Medical Home Model
6. Pharmaceutical Pricing and Reimbursement in Oncology - Payer Pressure to Justify Premium Pricing of Novel Agents, Pushing Companies to Risk-Sharing Modalities
7. Radiation Therapy in Oncology Drug Pipeline Update 2012
8. Medical Oncology Association of Southern California Purchasing Network (MPN) Names Cardinal Health Specialty Solutions as its Primary Healthcare Solutions Partner
9. Schulman Associates IRB offers oncology-focused review board
10. Debiopharm and Ascepion Pharmaceuticals, Inc. Announce an Exclusive License Agreement for the Development and Commercialisation of the Dual-Targeting Kinase Inhibitor, ASP-08126 (Debio 1144), for the Treatment of Oncology Diseases
11. Velos, Inc. Introduces Mobile App for Oncology Adverse Events and Graft-Versus-Host Disease at 2012 ASCO Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Inc. (ICBU) has repositioned itself as a holding company with ... in the hydroponic, hemp and medical marijuana sectors. By acquiring ... sector, and recently partnering with the Chippewa Tribe Nation to ... iMD is committing to bring its vision to the market ...
(Date:1/23/2015)... 2015   Leatt Corporation  (OTCQB: LEAT), a global developer, ... forms of sports, including extreme motor sports, and whose ... that the UISP Lega Motociclismo Lombardia, an Italian motocross ... wear a neck brace during its racing competitions.  ...
(Date:1/23/2015)... , Jan. 23, 2015 Gem Pharmaceuticals announced today ... been enrolled into the Company,s Phase 2 clinical trial. ... of Gem,s lead compound, GPX-150 (an investigational medication), in ... metastatic disease. Logo - http://photos.prnewswire.com/prnh/20150123/170966LOGO ...
Breaking Medicine Technology:iMD Companies Poised to Make Impact in Multi-Billion Dollar Medical Marijuana Sector With Recent Investments and Strategic Partnerships 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 2Leatt Announces Neck Braces Now Required For Motocross/Minicross Racing In Italy 3Gem Pharmaceuticals Announces Enrollment of Initial Patients in its Phase 2 Clinical Trial to Assess the Efficacy and Safety of GPX-150 in Sarcoma Patients 2
... Medical Group,s (FMG) subsidiaries, VasoStar Inc., Mentor, Ohio  today ... Frontier grant to further develop and commercialize a novel ... Occlusions (CTOs), in lieu of invasive open heart surgery ... VasoStar,s primary clinical development partner is the Cleveland ...
... July 20, 2011 Advanced Health Media (AHM), the ... solutions for the pharmaceutical industry, has named James Burgess ... assumes responsibility from Jeff Brady who has served as ... as its President for 9 years. James brings over ...
Cached Medicine Technology:Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 2Frantz Medical Group Subsidiary, VasoStar, Awarded $1 Million Research Grant 3Advanced Health Media Announces New CEO 2
(Date:1/22/2015)... 23, 2015 Angelweddingdress is a famous wedding ... its customers to follow it on Facebook, Twitter, and Pinterest. ... Day gift. Angelweddingdress draws a lottery every week. , Moreover, ... Feb. 28, 2015. Click Angelweddingdress homepage for more ...
(Date:1/22/2015)... 2015 A new white paper by ... person-centeredness in the long-term care environment as well as ... continuum. The paper, “The Power of Person-Centeredness in Long-Term ... practices of the patient, resident and family experience in ...
(Date:1/22/2015)... Joan Lunden, award-winning American journalist, beloved television ... 32nd Annual Miami Breast Cancer Conference planned ... (PER®) , shares that “a fast-growing, virulent” cancer in ... had not followed up her clean mammogram with an ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 Four years since the ... – which coincided with the marriage of Avasa & Matthew Love ... ROAD, which is scheduled for release through White Swan Records on ... that there is a sacred path available to all of us ...
(Date:1/22/2015)... has released a new blog post presenting a list of vehicles ... , Some types of vehicles cannot be covered under an ... post to see if their vehicle qualifies for auto insurance coverage. ... the cars that cannot be covered by a plan. Clients have ...
Breaking Medicine News(10 mins):Health News:Angelweddingdress Invites Its Customers To Follow It On Facebook, Twitter, And Pinterest 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 2Health News:The Power of Person-Centeredness in Long-Term Care Explored by The Beryl Institute 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 2Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 3Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 4Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 5Health News:Joan Lunden Reveals Diagnostic Approach That Led To Early Detection;To Keynote 32nd Annual Miami Breast Cancer Conference® 6Health News:THE ROAD by Avasa & Matthew Love -- A New Album 2Health News:THE ROAD by Avasa & Matthew Love -- A New Album 3Health News:THE ROAD by Avasa & Matthew Love -- A New Album 4Health News:Some Vehicles Cannot Be Covered By An Auto Insurance Policy! 2
... Includes PRIALT(R) (ziconotide intrathecal infusion) as a ... CHARLESTON, W.Va., Oct. 31 The 2007 ... national pain management,physicians from the United States and ... and recommendations. The findings,were released this month in ...
... BPUR ) announced today that the trading symbol ... to BPUR at the open of the market on,Wednesday, ... OTCBB,will revert to the following ticker symbols: BPREW reverting ... BPURL. Biopure Corporation Biopure Corporation develops, manufactures ...
... QUEBEC CITY, Oct. 31 /PRNewswire-FirstCall/ - AEterna Zentaris ... focused on,endocrine therapy and oncology, will announce its ... open on Wednesday, November,7, 2007. The Company will ... results on the same day at 10:00 a.m. ...
... WESTMINSTER, Colo., Oct. 31 Allos,Therapeutics, Inc. (Nasdaq: ... commercialization of small molecule therapeutics for,the treatment of cancer, ... present a corporate overview at the 2007 Acumen BioFin ... presentation will take place at 8:50 a.m. (Eastern) on,Tuesday, ...
... Total business authorizations of $831 million, an all-time Company high, - Third ... - Third quarter EPS of $0.25 (GAAP) and $0.48 (proforma), - Record ... ... 2006, CINCINNATI, Oct. 31 Kendle (Nasdaq: KNDL ), a,leading, ...
... (Amex: ANX ), a biopharmaceutical research and ... the treatment,of cancer and infectious diseases, announced today ... scheduled to present at the 18th,Annual CIBC Healthcare ... Time. The conference takes place in New York ...
Cached Medicine News:Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 2Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 3Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 4Health News:Polyanalgesic Consensus Panel's New Treatment Guidelines Via Intraspinal Infusion for Severe Chronic Pain 5Health News:Biopure's Stock Symbol Reverts to BPUR 2Health News:Allos Therapeutics to Present at the 2007 Acumen BioFin Rodman & Renshaw Conference 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 2Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 3Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 4Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 5Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 6Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 7Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 8Health News:Kendle Delivers Record Sales and Backlog and Strong Growth in Operating Margin for Third Quarter 2007 9Health News:ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference 2
Part of the Octopus System which includes both the Starfish & Octopus3. The Starfish Heart Positioner simplifies cardiac positioning and minimizes the associated hemodynamic deterioration when compa...
... Guidant's fourth generation access device - XPOSE ... the heart. The XPOSE 4 Device is ... off-pump bypass surgery and to easily position ... Designed for both apical and non-apical placement ...
... SUV vacuum stabilizer from Guidant. ... of use. The newest members of the ... with outstanding anastomotic site visibility and ... FlexLink technology on a stronger arm, ...
... ABIOMED's BVS 5000 has grown to become the ... the world to support recoverable hearts. It is ... and Drug Administration for all patients with potentially ... advances with the BVS 5000, expanding the patient ...
Medicine Products: